Currently, there are 21.24M common shares owned by the public and among those 13.41M shares have been available to trade.
Insiders at the company have transacted a total of 6 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 6 of these insider trades were purchases, accounting for 54,276 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of 79.65% and 329.17% over the past three months. VINC shares are trading 161.86% year to date (YTD), with the 12-month market performance up to 171.05% higher. It has a 12-month low price of $0.61 and touched a high of $1.95 over the same period. VINC has an average intraday trading volume of 559.15K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 124.24%, 171.55%, and 176.27% respectively.
Institutional ownership of Vincerx Pharma Inc (NASDAQ: VINC) shares accounts for 45.87% of the company’s 21.24M shares outstanding.
It has a market capitalization of $66.06M and a beta (3y monthly) value of 0.18. The earnings-per-share (ttm) stands at -$2.30. Price movements for the stock have been influenced by the stock’s volatility, which stands at 31.33% over the week and 17.35% over the month.
Analysts forecast that Vincerx Pharma Inc (VINC) will achieve an EPS of $INC for the current quarter, $25.08 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Vinco Ventures, Inc. while analysts give the company a high EPS estimate of $EINC. Comparatively, EPS for the current quarter was $Vince Holding Corp. a year ago. Earnings per share for the fiscal year are expected to increase by 34.41%, and 50.49% over the next financial year.
Looking at the support for the VINC, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on January 14, 2022, with the firm’s price target at $25. Cantor Fitzgerald coverage for the Vincerx Pharma Inc (VINC) stock in a research note released on December 23, 2021 offered a Overweight rating with a price target of $25. SVB Leerink was of a view on November 01, 2021 that the stock is Outperform, while Laidlaw gave the stock Buy rating on September 13, 2021, issuing a price target of $30. B. Riley Securities on their part issued Buy rating on August 25, 2021.
